Eye Care News — ScienceDaily Learn about glaucoma symptoms and cataracts, as well as laser eye surgery and optic nerve regeneration. Read the latest medical research on diagnosis and new treatment options.
- Eye drops slow nearsightedness progression in kidson June 1, 2023 at 10:29 pm
The results of a new clinical trial suggest that the first drug therapy to slow the progression of nearsightedness in kids could be on the horizon. The three-year study found that a daily drop in each eye of a low dose of atropine, a drug used to dilate pupils, was better than a placebo at limiting eyeglass prescription changes and inhibiting elongation of the eye in nearsighted children aged 6 to 10.
- Preventing truck crashes needs to take ‘dashcam’ approach to driver ‘microsleeps’on June 1, 2023 at 8:02 pm
Researchers using dashcam footage of real-world collisions involving large trucks to analyze driver and vehicle behavior has found that anti-drowsiness alarms or similar technologies to prevent falling asleep at the wheel need to go beyond a focus on monitoring the drivers’ eyes, and consider other microsleep behaviors including a relaxation of back and neck muscles and abnormal activity of the vehicle itself.
- Experimental drug inhibits or prevents diabetic eye diseaseon May 25, 2023 at 6:14 pm
Researchers say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as human retinal organoids and eye cell lines.
- One step closer to developing a potentially ultraprotective sunscreen from our own melaninon May 18, 2023 at 4:08 pm
Researchers have announced a major advance in understanding the fundamental structure of melanin and one of its components that turns light into heat, protecting the body from sun damage.
- Gene responsible for severe facial defects identifiedon May 4, 2023 at 1:49 pm
Goldenhar syndrome is a rare congenital disease, affecting early fetal development. This syndrome includes malformations of varying severity, affecting different parts of the face. Its causes and modes of transmission are still poorly understood. An international collaboration has discovered that pathogenic variants of the FOXI3 gene — responsible for the development of the ear — cause one form of this developmental disorder. The scientists were also able to identify the modes of transmission of the disease when this particular gene is involved.
ONE News Feed This is a ONE News feed
- High-dose bevacizumab therapy may lead to less need for retreatment for ROPon June 1, 2023 at 8:46 pm
For retinopathy of prematurity (ROP), treating with high-dose bevacizumab vs low-dose bevacizumab or any dose of ranibizumab may mean a lower rate of retreatment.
- Reducing patient no-show rates in pediatric ophthalmology can improve careon May 31, 2023 at 6:51 pm
Missed pediatric ophthalmology appointments can translate to poor vision care for the patient and lost hours and income for the ophthalmologist, but targeted strategies can help reduce no-show rates and ensure continuity of care.
- COVID-19 vaccine can be given to patients whose uveitis is not in remissionon May 30, 2023 at 6:00 pm
An increased incidence of new-onset uveitis or uveitis relapse following COVID-19 vaccination has been noted in the literature. Proper timing of vaccination is key to minimizing risk of uveitis flares and worsening disease.
- Mycophenolate may be superior to other immunomodulators for treating OcMMPon May 29, 2023 at 9:52 pm
Patients with ocular mucous membrane pemphigoid (OcMMP) may benefit most from mycophenolate or a mycophenolate–rituximab combination treatment.
- Amsler grid may not be as reliable as once thought for self-monitoring AMDon May 26, 2023 at 9:18 pm
Despite ease of use, the Amsler grid may not have adequate sensitivity or specificity to make it a reliable at-home tool for monitoring the progression of AMD.